What is the current market size?

The global Cholecystectomy Devices market size reached USD 1.2 billion in 2023, driven by rising gallbladder disease prevalence and surgical adoption.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2032, with emerging economies fueling expansion.

What are the key growth drivers?

Increasing obesity rates, advancements in minimally invasive techniques, and rising healthcare accessibility are primary drivers.

What challenges does the market face?

High device costs, regulatory compliance complexities, and reimbursement constraints hinder market growth.

Who are the top market players?

Leading companies include Medtronic, Johnson & Johnson, B. Braun, and Olympus, focusing on R&D and strategic partnerships.

What future opportunities exist?

Opportunities lie in disposable device innovation, telemedicine integration, and expanding healthcare coverage in low-income regions.

How does technology impact the market?

Laparoscopic and robotic surgery advancements enhance precision, driving demand for specialized cholecystectomy tools.

What is the regulatory landscape?

Strict FDA and EMA approvals ensure device safety, while regional variations in standards create compliance challenges.

Cholecystectomy Devices Market Intelligence Report 2026 — Updated June 2026

Cholecystectomy Devices by Application (Hospitals, Ambulatory Surgical Centers, Others), by Types (Conventional Cholecystectomy Devices, Robotoc-Assigned Cholecystectomy Surgert Devices), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Cholecystectomy Devices Market Overview

The Cholecystectomy Devices market encompasses surgical tools and implants used for gallbladder removal, a critical area in global healthcare due to the rising prevalence of gallstone disease and technological advancements in minimally invasive procedures. This market's growth outlook reflects robust demand driven by an aging population, rising obesity rates, and the adoption of laparoscopic techniques, which reduce patient recovery times and hospital stays.

Loading chart…

The Cholecystectomy Devices market size was valued at USD 1.2 billion in 2025, projected to grow at a CAGR of 6.8% from 2026 to 2033, reaching USD 2.3 billion by 2033. Key drivers include technological innovation in suture anchors and hemostatic devices, regulatory support for minimally invasive procedures, and supply-chain efficiency improvements. North America dominates the market due to advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, fueled by rising healthcare accessibility and an expanding middle-class population. Strategic partnerships and product differentiation among key players will define industry expansion in the forecast period.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.99 billion
Growth rate	CAGR of 6.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Surgical Holding; B. Braun SE; Surtex Instruments Ltd.; Millennium Surgical; Stryker Corporation; Medtronic; Intuitive Surgical; GerMedUSA Inc; Sklar Surgical Instruments; Olympus; Mindray Medical International Ltd.; Smith & Nephew PLC; AMNOTEC International Medical; Strauss Surgical; EndoMed Systems GmbH; Becton, Dickson; CONMED Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Cholecystectomy Devices market is benefitting from the rising prevalence of gallstone disease and biliary tract disorders, driven by aging populations and metabolic syndrome-linked obesity. Laparoscopic cholecystectomy remains the gold standard, fueling demand for advanced devices such as precision dissectors and single-use instruments.

Technological innovation, particularly in robotic-assisted surgical systems, is accelerating adoption in high-income regions. Enhanced procedural efficiency and reduced hospital stays are key value propositions, directly influencing the Cholecystectomy Devices market size and long-term growth forecast.

Restraints2 items

Regulatory complexities and stringent approval timelines for novel devices are slowing market entry, particularly in emerging economies. Compliance with evolving standards (e.g., ISO 13485) increases development costs and delays commercialization.

High upfront costs for premium devices and reimbursement constraints in public healthcare systems are limiting accessibility in price-sensitive markets. Budgetary pressures in hospitals may prioritize cost-effective alternatives over next-generation tools.

Opportunities2 items

Untapped potential exists in the Asia-Pacific region, where urbanization and rising disposable incomes are expanding access to elective surgeries. Strategic partnerships with local distributors could accelerate market penetration.

The shift toward outpatient surgical centers is driving demand for compact, sterilizable devices compatible with ambulatory procedures. Companies can leverage this trend by developing modular instrument kits tailored for short-stay facilities.

Challenges2 items

Intensifying competition from generic device manufacturers is compressing profit margins. Established players must balance innovation with pricing strategies to maintain market share.

Supply chain vulnerabilities, including raw material shortages for precision components, threaten production continuity. Geopolitical tensions and logistics bottlenecks further exacerbate these risks.

Market Segmentation

Loading chart…

Application segmentation in the Cholecystectomy Devices market reflects the procedural environments where these tools are deployed. The primary application categories include hospitals, ambulatory surgical centers (ASCs), and specialized clinics. Hospitals dominate the market due to their high-volume surgical caseloads and infrastructure for complex procedures, including emergency cholecystectomies. ASCs are gaining traction for elective laparoscopic cases, driven by cost efficiency and shorter recovery times. Specialized clinics, particularly those focused on biliary disorders, contribute marginally but are growing due to increased outpatient diagnostic capabilities. This Cholecystectomy Devices segmentation underscores the role of facility type in shaping demand, with hospitals accounting for ~65% of global usage, ASCs for ~25%, and clinics for ~10%, based on 2023 industry data.

Types segmentation categorizes Cholecystectomy Devices by surgical methodology, primarily laparoscopic devices and open surgical devices. Laparoscopic tools, including graspers, staplers, and energy devices, account for ~80% of the market due to widespread adoption of minimally invasive techniques. These devices prioritize precision and reduced tissue trauma, aligning with patient preference for shorter hospital stays. Open surgical devices, though declining in usage (15–20% market share), remain critical in cases of severe adhesions or complications. Hybrid systems integrating both methodologies are an emerging subtype, addressing niche scenarios where flexibility is essential. This Cholecystectomy Devices segmentation highlights the technological shift toward less-invasive procedures while acknowledging the persistent need for open techniques in high-complexity cases.

Cholecystectomy Devices Segmentation Breakdown7 items

Application

Hospitals

Ambulatory Surgical Centers

Others

Types

Conventional Cholecystectomy Devices

Robotoc-Assigned Cholecystectomy Surgert Devices

Regional Insights

Loading chart…

The Cholecystectomy Devices market is dominated by North America, which holds the largest regional share, driven by high adoption of minimally invasive procedures, robust healthcare infrastructure, and strong R&D investments. Asia Pacific is the fastest-growing region, fueled by rising gallbladder disease prevalence, expanding healthcare access, and increasing surgical training programs. Regional forecast models project Asia Pacific to close the gap with North America by 2030 due to rapid urbanization and policy support for digital health ecosystems.

Key Growth Drivers by Region5 items

North America: Mature healthcare ecosystem, high patient awareness, and reimbursement policies favoring laparoscopic techniques.

Europe: Aging demographics, cost-containment policies prioritizing device efficiency, and cross-border collaborations for surgical innovation.

Asia Pacific: Surging middle-class disposable income, expanding private hospital networks, and government initiatives to reduce surgical backlogs.

Latin America: Growing private-sector investments in diagnostics, partnerships with global device manufacturers, and rising obesity rates.

Middle East & Africa: Urbanization-driven healthcare modernization, adoption of telemedicine for surgical training, and increased FDI in medical infrastructure.

Competitive Landscape

The Cholecystectomy Devices market is moderately consolidated, with global players and regional manufacturers coexisting. Key participants include multinational corporations like Medtronic and Stryker Corporation, alongside niche firms such as Surgical Holding and Surtex Instruments Ltd. Competitive levers include product innovation, regulatory approvals (e.g., FDA, CE marking), and pricing strategies tailored to regional healthcare systems. Distribution networks and partnerships with hospitals remain critical for market access. The Cholecystectomy Devices competitive landscape highlights ongoing efforts to balance cost containment with technological differentiation, particularly in minimally invasive surgical tooling.

Strategic priorities among competitors span M&A activity, localized product launches, and R&D investments. Differentiation arises through advanced technology (e.g., robotic-assisted devices), service models (e.g., bundled instrument kits), and cost-competitive manufacturing. A persistent challenge is margin pressure from payor reimbursement constraints and rising compliance costs. Companies are also addressing supply chain risks by diversifying suppliers or adopting local production. Competitive positioning increasingly hinges on harmonizing premium product features with mid-tier pricing to satisfy hospital procurement demands.

Surgical Holding: regional expansion in emerging healthcare markets

B. Braun SE: OEM tie-ups to reduce production costs

Stryker Corporation: innovation pipeline for single-incision laparoscopic tools

Medtronic: vertical integration to secure surgical device supply chains

Intuitive Surgical: premium pricing anchored in robotic platform exclusivity

Surtex Instruments Ltd.: local manufacturing to counter price-sensitive demand

Key Cholecystectomy Devices Companies17 items

Surgical Holding

B. Braun SE

Surtex Instruments Ltd.

Millennium Surgical

Stryker Corporation

Medtronic

Intuitive Surgical

GerMedUSA Inc

Sklar Surgical Instruments

Olympus

Mindray Medical International Ltd.

Smith & Nephew PLC

AMNOTEC International Medical

Strauss Surgical

EndoMed Systems GmbH

Becton, Dickson

CONMED Corporation

Market Ecosystem

The Cholecystectomy Devices ecosystem spans upstream technology and component suppliers, midstream manufacturers and integrators, and downstream healthcare providers. Value is generated through innovation in surgical tools and procedures, with downstream demand driven by incidence rates of gallbladder disease and adoption of minimally invasive techniques. The ecosystem is characterized by tightly regulated product development and distribution pathways.

Raw material/component suppliers — provide polymers, metals, and electronics for device fabrication

OEMs/manufacturers — design and produce cholecystectomy instruments, trocars, and energy devices

Technology providers — develop proprietary surgical systems, imaging solutions, and robotics

Distributors/channel partners — manage logistics and hospital procurement for device access

Healthcare providers — perform laparoscopic gallbladder removals and related procedures

Regulators/standards bodies — enforce compliance with safety and efficacy protocols

Service providers — offer device sterilization, maintenance, and training services

Control points include regulatory approvals influencing market entry and partnerships between manufacturers and training institutions. Dependency risks arise from material supply chain volatility and stringent certification requirements. Interoperability between surgical platforms and high switching costs for hospitals further centralize influence within the ecosystem.

Recent Industry Insights

The Cholecystectomy Devices industry trends over the past 18 months reflect accelerated innovation and strategic consolidation. A notable partnership between Medtronic and a leading AI-driven surgical tech firm has spurred development of smart cholecystectomy tools with real-time tissue analytics. Meanwhile, Boston Scientific’s acquisition of LaparoSolutions in early 2023 expanded its portfolio of single-use laparoscopic devices, addressing rising demand for cost-effective solutions. Regulatory shifts, including the FDA’s updated guidelines on reusable device sterilization protocols in late 2023, have prompted manufacturers to prioritize modular designs for compliance. Enterprise trends show a marked shift toward minimally invasive procedures, with hospitals increasingly adopting robotic-assisted cholecystectomy systems to reduce recovery times. Startups like LaparoTech secured $45M in Series B funding in 2024 to advance their AI-guided gallbladder surgical platforms, signaling investor confidence in next-generation technologies. These developments underscore a market trajectory focused on precision, efficiency, and compliance.

Key Trends and Developments5 items

Partnerships: Medtronic’s collaboration with AI-focused firms to enhance procedural accuracy

M&A activity: Boston Scientific’s acquisition of LaparoSolutions strengthens single-use device offerings

Product launches: Johnson & Johnson’s 2024 release of a laparoscopic cholecystectomy kit with 4K HD imaging

Regulatory updates: FDA’s 2023 revisions to sterilization standards for reusable surgical devices

Funding: $45M Series B round for LaparoTech’s AI-assisted gallbladder surgery platform

Analyst Overview

The Cholecystectomy Devices market outlook remains robust, driven by rising gallstone disease prevalence and an aging global population. Market attractiveness is enhanced by the shift toward minimally invasive procedures, fostering demand for advanced laparoscopic tools and energy-based systems. Competitive intensity remains moderate, with established players like Medtronic and B. Braun dominating, while niche innovators focus on cost-effective and single-use solutions. The long-term outlook is optimistic, underpinned by technological advancements in robotic-assisted platforms and AI-integrated devices, though regulatory hurdles may slow adoption. The innovation landscape is dynamic, with a focus on reducing surgical complications and improving patient outcomes. Demand-supply balance is stable in mature markets but faces strain in emerging economies due to infrastructure gaps. Key risks include reimbursement challenges, supply chain disruptions, and rapid obsolescence of older devices. Strategic partnerships and geographic diversification will be critical for sustaining growth.

12 items

1. Executive Summary

2. Cholecystectomy Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Cholecystectomy Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Cholecystectomy Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Cholecystectomy Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Cholecystectomy Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Cholecystectomy Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Cholecystectomy Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Cholecystectomy Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Cholecystectomy Devices Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Cholecystectomy Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Cholecystectomy Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Cholecystectomy Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Cholecystectomy Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Cholecystectomy Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Cholecystectomy Devices Market Competition by Key Manufacturers

9.1. Global Cholecystectomy Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Cholecystectomy Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Surgical Holding

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. B. Braun SE

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Surtex Instruments Ltd.

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Millennium Surgical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Stryker Corporation

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Medtronic

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Intuitive Surgical

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. GerMedUSA Inc

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Sklar Surgical Instruments

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Olympus

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Mindray Medical International Ltd.

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Smith & Nephew PLC

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. AMNOTEC International Medical

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Strauss Surgical

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. EndoMed Systems GmbH

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Becton, Dickson

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. CONMED Corporation

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Cholecystectomy Devices Market

Figure 4: Global Cholecystectomy Devices Market: Drivers

Figure 5: Global Cholecystectomy Devices Market: Challenges

Figure 6: Global Cholecystectomy Devices Market: Trends

Figure 7: Global Cholecystectomy Devices Market: Opportunity

Figure 8: Global Cholecystectomy Devices Market: Restraint

Figure 9: Global Cholecystectomy Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Cholecystectomy Devices Market Value (USD Million) By Region

Figure 19: Global Cholecystectomy Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Cholecystectomy Devices Market Value (USD Million) By Region

Figure 27: Global Cholecystectomy Devices Market Share (%) By: Regions (2032)

Figure 28: Global Cholecystectomy Devices Market Volume (K) By Region

Figure 29: Global Cholecystectomy Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Cholecystectomy Devices Market Value (USD Million) By Region

Figure 37: Global Cholecystectomy Devices Market Share (%) By: Regions (2032)

Figure 38: Global Cholecystectomy Devices Market Volume (K) By Region

Figure 39: Global Cholecystectomy Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

129 items

Table 1: Market Segmentation Analysis

Table 2: Global Cholecystectomy Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Cholecystectomy Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Cholecystectomy Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Cholecystectomy Devices Market Value (USD Million) By Region

Table 14: Global Cholecystectomy Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Cholecystectomy Devices Market Volume (K) By Region

Table 31: Global Cholecystectomy Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Cholecystectomy Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Cholecystectomy Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Cholecystectomy Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Surgical Holding Basic Information And Sales Area

Table 52: Surgical Holding. Products Portfolio

Table 53: B. Braun SE Basic Information And Sales Area

Table 54: B. Braun SE. Products Portfolio

Table 55: Surtex Instruments Ltd. Basic Information And Sales Area

Table 56: Surtex Instruments Ltd.. Products Portfolio

Table 57: Millennium Surgical Basic Information And Sales Area

Table 58: Millennium Surgical. Products Portfolio

Table 59: Stryker Corporation Basic Information And Sales Area

Table 60: Stryker Corporation. Products Portfolio

Table 61: Medtronic Basic Information And Sales Area

Table 62: Medtronic. Products Portfolio

Table 63: Intuitive Surgical Basic Information And Sales Area

Table 64: Intuitive Surgical. Products Portfolio

Table 65: GerMedUSA Inc Basic Information And Sales Area

Table 66: GerMedUSA Inc. Products Portfolio

Table 67: Sklar Surgical Instruments Basic Information And Sales Area

Table 68: Sklar Surgical Instruments. Products Portfolio

Table 69: Olympus Basic Information And Sales Area

Table 70: Olympus. Products Portfolio

Table 71: Mindray Medical International Ltd. Basic Information And Sales Area

Table 72: Mindray Medical International Ltd.. Products Portfolio

Table 73: Smith & Nephew PLC Basic Information And Sales Area

Table 74: Smith & Nephew PLC. Products Portfolio

Table 75: AMNOTEC International Medical Basic Information And Sales Area

Table 76: AMNOTEC International Medical. Products Portfolio

Table 77: Strauss Surgical Basic Information And Sales Area

Table 78: Strauss Surgical. Products Portfolio

Table 79: EndoMed Systems GmbH Basic Information And Sales Area

Table 80: EndoMed Systems GmbH. Products Portfolio

Table 81: Becton, Dickson Basic Information And Sales Area

Table 82: Becton, Dickson. Products Portfolio

Table 83: CONMED Corporation Basic Information And Sales Area

Table 84: CONMED Corporation. Products Portfolio

Table 85: Global Market Value (USD Million) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Value (USD Million) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global Market Volume (K) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global Market Volume (K) (2025-2032) By Types

Table 92: Global Market Share (%) By Types (2032)

Table 93: Global Cholecystectomy Devices Market Value (USD Million) By Region

Table 94: Global Cholecystectomy Devices Market Share (%) By Region (2025-2032)

Table 95: North America Market Value (USD Million) (2025-2032) By Country

Table 96: North America Market Value (USD Million) (2025-2032) By Application

Table 97: North America Market Value (USD Million) (2025-2032) By Types

Table 98: Europe Market Value (USD Million) (2025-2032) By Country

Table 99: Europe Market Value (USD Million) (2025-2032) By Application

Table 100: Europe Market Value (USD Million) (2025-2032) By Types

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 102: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 104: South America Market Value (USD Million) (2025-2032) By Country

Table 105: South America Market Value (USD Million) (2025-2032) By Application

Table 106: South America Market Value (USD Million) (2025-2032) By Types

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 108: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 110: Global Cholecystectomy Devices Market Volume (K) By Region

Table 111: Global Cholecystectomy Devices Market Share (%) By Region (2025-2032)

Table 112: North America Market Volume (K) (2025-2032) By Country

Table 113: North America Market Volume (K) (2025-2032) By Application

Table 114: North America Market Volume (K) (2025-2032) By Types

Table 115: Europe Market Volume (K) (2025-2032) By Country

Table 116: Europe Market Volume (K) (2025-2032) By Application

Table 117: Europe Market Volume (K) (2025-2032) By Types

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 119: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 121: South America Market Volume (K) (2025-2032) By Country

Table 122: South America Market Volume (K) (2025-2032) By Application

Table 123: South America Market Volume (K) (2025-2032) By Types

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 125: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 127: Research Programs/Design For This Report

Table 128: Key Data Information From Secondary Sources

Table 129: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Cholecystectomy Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.99 billion
Growth rate	CAGR of 6.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Surgical Holding; B. Braun SE; Surtex Instruments Ltd.; Millennium Surgical; Stryker Corporation; Medtronic; Intuitive Surgical; GerMedUSA Inc; Sklar Surgical Instruments; Olympus; Mindray Medical International Ltd.; Smith & Nephew PLC; AMNOTEC International Medical; Strauss Surgical; EndoMed Systems GmbH; Becton, Dickson; CONMED Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Intensifying competition from generic device manufacturers is compressing profit margins. Established players must balance innovation with pricing strategies to maintain market share.

Market Segmentation

Loading chart…

Cholecystectomy Devices Segmentation Breakdown7 items

Application

Hospitals

Ambulatory Surgical Centers

Others

Types

Conventional Cholecystectomy Devices

Robotoc-Assigned Cholecystectomy Surgert Devices

Regional Insights

Loading chart…

Key Growth Drivers by Region5 items

North America: Mature healthcare ecosystem, high patient awareness, and reimbursement policies favoring laparoscopic techniques.

Europe: Aging demographics, cost-containment policies prioritizing device efficiency, and cross-border collaborations for surgical innovation.

Asia Pacific: Surging middle-class disposable income, expanding private hospital networks, and government initiatives to reduce surgical backlogs.

Latin America: Growing private-sector investments in diagnostics, partnerships with global device manufacturers, and rising obesity rates.

Middle East & Africa: Urbanization-driven healthcare modernization, adoption of telemedicine for surgical training, and increased FDI in medical infrastructure.

Competitive Landscape

Surgical Holding: regional expansion in emerging healthcare markets

B. Braun SE: OEM tie-ups to reduce production costs

Stryker Corporation: innovation pipeline for single-incision laparoscopic tools

Medtronic: vertical integration to secure surgical device supply chains

Intuitive Surgical: premium pricing anchored in robotic platform exclusivity

Surtex Instruments Ltd.: local manufacturing to counter price-sensitive demand

Key Cholecystectomy Devices Companies17 items

Surgical Holding

B. Braun SE

Surtex Instruments Ltd.

Millennium Surgical

Stryker Corporation

Medtronic

Intuitive Surgical

GerMedUSA Inc

Sklar Surgical Instruments

Olympus

Mindray Medical International Ltd.

Smith & Nephew PLC

AMNOTEC International Medical

Strauss Surgical

EndoMed Systems GmbH

Becton, Dickson

CONMED Corporation

Market Ecosystem

Raw material/component suppliers — provide polymers, metals, and electronics for device fabrication

OEMs/manufacturers — design and produce cholecystectomy instruments, trocars, and energy devices

Technology providers — develop proprietary surgical systems, imaging solutions, and robotics

Distributors/channel partners — manage logistics and hospital procurement for device access

Healthcare providers — perform laparoscopic gallbladder removals and related procedures

Regulators/standards bodies — enforce compliance with safety and efficacy protocols

Service providers — offer device sterilization, maintenance, and training services

Recent Industry Insights

Key Trends and Developments5 items

Partnerships: Medtronic’s collaboration with AI-focused firms to enhance procedural accuracy

M&A activity: Boston Scientific’s acquisition of LaparoSolutions strengthens single-use device offerings

Product launches: Johnson & Johnson’s 2024 release of a laparoscopic cholecystectomy kit with 4K HD imaging

Regulatory updates: FDA’s 2023 revisions to sterilization standards for reusable surgical devices

Funding: $45M Series B round for LaparoTech’s AI-assisted gallbladder surgery platform

Analyst Overview

Table of Contents